Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today the appointment of Doug Hecker as Head of Technical Operations. With over 30 years of ...
Designed using protein structure-augmented machine learning tools ... and S-4321 is a non-depleting bifunctional PD‑1: FcγRIIb‑selective agonist antibody for the treatment of autoimmune ...
Clinical Trials Arena on MSN10d
NiKang concludes first cohort dosing in Phase I trial of NKT3964 for tumoursNiKang Therapeutics has concluded the first cohort dosing in the open-label Phase I trial of NKT3964 as a monotherapy for ...
It has a unique chemical structure differentiated from all the ... ovarian cancer and PD-1/ PD-L1 drug-resistant solid tumors. LAE002 (afuresertib) is a potent AKT inhibitor that inhibits all ...
In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to ...
About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability ...
About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body's ability to ...
Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback